Crinetics (CRNX) Stock Skyrockets on FDA Approval – Full 2025 Investor Update
Stock Price Performance (YTD & Recent) Crinetics stock has been volatile but trending upward in 2025, with the recent FDA catalyst propelling it sharply higher. On September 26, 2025, CRNX closed around $45–$46, up roughly +28% in a single day